SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
9 references·8 citing·43 second hop
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities (2015)Psychedelics and Immunomodulation: Novel …Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal (2024)Two new Later Stone Age sites…Systematic review and meta-analysis (2019)Systematic review and meta-an…Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model (2012)Head‐twitch response in roden…Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists (2011)Metabotropic glutamate mGlu2 …Psychedelics and the Human Receptorome (2010)Psychedelics and the Human Re…The Pharmacology of Lysergic Acid Diethylamide: A Review (2008)The Pharmacology of Lysergic …Serotonin and Hallucinogens (1999)Serotonin and HallucinogensPharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites (1988)Pharmacologic profile of MDMA…Dimethyltryptamin: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism (1956)Dimethyltryptamin: Its metabo…Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study (2023)Psilocybin induces acute and …Introduction (2023)IntroductionThe clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) (2022)The clinical pharmacology and…From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders (2021)From psychiatry to neurology:…Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin (2020)Exploratory Controlled Study …Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review (2020)Depression, Mindfulness, and …Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment (2019)Prospective examination of sy…Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT (2017)Short term changes in the pro…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Hallucinogens (2004)Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Characterization of the head-twitch response induced by hallucinogens in mice (2013)The promises and perils of psychedelic pharmacology for psychiatry (2022)A non-hallucinogenic LSD analog with therapeutic potential for mood disorders (2023)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram (2000)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations (2003)Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex (2003)Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways (2017)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Classic hallucinogens in the treatment of addictions (2015)Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Psychopharmacology: The Third Generation of Progress. (1988)Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects (2014)LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects (2014)The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation (2017)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Psilocybin – Summary of knowledge and new perspectives (2013)Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species (2020)Meta-analysis in clinical trials (1986)Measuring inconsistency in meta-analyses (2003)Time to retire the theory of planned behaviour (2013)Suicide and suicidal behaviour (2015)Understanding and Promoting Effective Engagement With Digital Behavior Change Interventions (2016)Human hallucinogen research: guidelines for safety (2008)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants (2022)Therapeutic use of psilocybin: Practical considerations for dosing and administration (2022)Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants (2023)Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: A comparative iontophoretic study with LSD and serotonin (1977)Clinical applications of hallucinogens: A review. (2016)N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function (2018)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017)
this work references cited by second hop

References

  • 2024Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal23,871 cited
  • 2019Systematic review and meta-analysis2,659 cited
  • 2008The Pharmacology of Lysergic Acid Diethylamide: A Review455 cited
  • 1999Serotonin and Hallucinogens371 cited
  • 2010Psychedelics and the Human Receptorome302 cited
  • 1988Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites301 cited
  • 2011Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists235 cited
  • 2012Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model221 cited
  • 1956Dimethyltryptamin: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism203 cited

Cited by

  • 2020Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin139 cited
  • 2017Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT134 cited
  • 2019Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment117 cited
  • 2022The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

112 cited
  • 2023Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study88 cited
  • 2020Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review86 cited
  • 2021From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders81 cited
  • 2023Introduction1 cited